Sartorius Stedim Biotech SA (SSB) provides equipment and services to the pharmaceutical and biotechnology industries. Its products are used in various applications such as life science research, biopharmaceutical manufacturing, quality control and testing, and applied industries such as food and beverage, environmental, paint mixing, cannabis testing, and medical devices. The company operates Biopharm segment (Bioprocess Solutions division) of Sartorius Group.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

The company focused on the expansion of its production capacity by investing in the development of development of its products and new technologies. It aims to expanding sites in Germany, France, Puerto Rico, the USA, South Korea, and China, among other countries. The company owns total of 4,067 patents. It has 267 registered patents and trademarks whereas it has 171 patent and trademark applications. In FY2022, the company reported expenses of EUR132.4 million, which is 3.8% company’s total revenue.